• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Institut Pasteur: Introductions and early spread of SARS-CoV-2 in France

sharon sanders

Editor-in-Chief & President
des nouvelles du jour :
"Une ?tude g?n?tique men?e par l'Institut Pasteur laisse entendre que la diffusion de l'?pid?mie dans l'Hexagone serait pour tr?s peu li?e ? des cas import?s de Chine ou d'Italie. Une troisi?me souche ? l'origine pour l'instant inconnue expliquerait la forte diffusion de l'?pid?mie dans l'Hexagone."
https://www.lesechos.fr/economie-fra...italie-1199167


Introductions and early spread of SARS-CoV-2 in France

Fabiana G?mbaro, Sylvie Behillil, Artem Baidaliuk, Flora Donati, M?lanie Albert, Andreea Alexandru, Maud Vanpeene, M?line Bizard, Angela Brisebarre, M arion Barbet, Fawzi Derrar, Sylvie van der Werf, Vincent Enouf, View ORCID ProfileEtienne Simon-Loriere
doi: https://doi.org/10.1101/2020.04.24.059576
This article is a preprint and has not been certified by peer review [what does this mean?].
Abstract


Following the emergence of coronavirus disease (COVID-19) in Wuhan, China in December 2019, specific COVID-19 surveillance was launched in France on January 10, 2020. Two weeks later, the first three imported cases of COVID-19 into Europe were diagnosed in France. We sequenced 97 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomes from samples collected between January 24 and March 24, 2020 from infected patients in France. Phylogenetic analysis identified several early independent SARS-CoV-2 introductions without local transmission, highlighting the efficacy of the measures taken to prevent virus spread from symptomatic cases. In parallel, our genomic data reveals the later predominant circulation of a major clade in many French regions, and implies local circulation of the virus in undocumented infections prior to the wave of COVID-19 cases. This study emphasizes the importance continuous and geographically broad genomic sequencing and calls for further efforts with inclusion of asymptomatic infections.


https://www.biorxiv.org/content/10.1...04.24.059576v1
 
Back
Top Bottom